Phreesia Cost of Goods Sold 2019-2025 | PHR

Phreesia cost of goods sold from 2019 to 2025. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Phreesia Annual Cost of Goods Sold
(Millions of US $)
2025 $135
2024 $124
2023 $109
2022 $81
2021 $52
2020 $45
2019 $37
2018 $30
Phreesia Quarterly Cost of Goods Sold
(Millions of US $)
2025-01-31 $34
2024-10-31 $35
2024-07-31 $33
2024-04-30 $34
2024-01-31 $32
2023-10-31 $31
2023-07-31 $30
2023-04-30 $31
2023-01-31 $28
2022-10-31 $27
2022-07-31 $27
2022-04-30 $27
2022-01-31 $22
2021-10-31 $21
2021-07-31 $20
2021-04-30 $18
2021-01-31 $15
2020-10-31 $14
2020-07-31 $12
2020-04-30 $12
2020-01-31 $11
2019-10-31 $11
2019-07-31 $11
2019-04-30 $11
2019-01-31
2018-10-31 $9
2018-07-31 $9
2018-01-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.434B $0.420B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.774B 53.56
Hims & Hers Health (HIMS) United States $11.630B 121.74
Tempus AI (TEM) United States $10.119B 0.00
Inspire Medical Systems (INSP) United States $4.616B 72.12
IRhythm Technologies (IRTC) United States $4.348B 0.00
Privia Health (PRVA) United States $2.829B 212.00
Enovis (ENOV) United States $1.955B 12.10
Clover Health Investments (CLOV) United States $1.926B 0.00
Schrodinger (SDGR) United States $1.732B 0.00
Azenta (AZTA) United States $1.154B 53.74
Omnicell (OMCL) United States $1.154B 20.35
10x Genomics (TXG) United States $1.016B 0.00
Fulgent Genetics (FLGT) United States $0.568B 0.00
Butterfly Network (BFLY) United States $0.530B 0.00
Talkspace (TALK) United States $0.512B 152.00
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.387B 0.00
TruBridge (TBRG) United States $0.381B 850.00
Claritev (CTEV) United States $0.344B 0.00
Health Catalyst (HCAT) United States $0.279B 0.00
Nyxoah SA (NYXH) Belgium $0.215B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
Pulmonx (LUNG) United States $0.148B 0.00
American Well (AMWL) United States $0.106B 0.00
Retrieve Medical Holdings (RMHI) United States $0.094B 0.00
EUDA Health Holdings (EUDA) Singapore $0.092B 0.00
MDxHealth SA (MDXH) Belgium $0.081B 0.00
CareCloud (CCLD) United States $0.080B 3.03
111 (YI) China $0.064B 0.00
HeartBeam (BEAT) United States $0.063B 0.00
P3 Health Partners (PIII) United States $0.062B 0.00
Outset Medical (OM) United States $0.042B 0.00
Zepp Health (ZEPP) Netherlands $0.038B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.015B 0.00
Streamline Health Solutions (STRM) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00